Clinical Trials Browser

INDUSTRY × talazoparib × Tumor-Agnostic × Clear all

NCT05097599 2025-01-08

StrataPATH

Phase 2 Terminated

Neoplasms

NCT02921919 2022-08-24

Open-Label Extension and Safety Study of Talazoparib

Phase 2 Completed

120 enrolled 16 charts

Neoplasms